IBDEI10N ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16523,1,4,0)
;;=4^D57.02
;;^UTILITY(U,$J,358.3,16523,2)
;;=^5002308
;;^UTILITY(U,$J,358.3,16524,0)
;;=D68.32^^61^775^89
;;^UTILITY(U,$J,358.3,16524,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16524,1,3,0)
;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
;;^UTILITY(U,$J,358.3,16524,1,4,0)
;;=4^D68.32
;;^UTILITY(U,$J,358.3,16524,2)
;;=^5002357
;;^UTILITY(U,$J,358.3,16525,0)
;;=C22.2^^61^775^90
;;^UTILITY(U,$J,358.3,16525,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16525,1,3,0)
;;=3^Hepatoblastoma
;;^UTILITY(U,$J,358.3,16525,1,4,0)
;;=4^C22.2
;;^UTILITY(U,$J,358.3,16525,2)
;;=^5000935
;;^UTILITY(U,$J,358.3,16526,0)
;;=D58.9^^61^775^92
;;^UTILITY(U,$J,358.3,16526,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16526,1,3,0)
;;=3^Hereditary Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,16526,1,4,0)
;;=4^D58.9
;;^UTILITY(U,$J,358.3,16526,2)
;;=^5002322
;;^UTILITY(U,$J,358.3,16527,0)
;;=C81.99^^61^775^93
;;^UTILITY(U,$J,358.3,16527,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16527,1,3,0)
;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,16527,1,4,0)
;;=4^C81.99
;;^UTILITY(U,$J,358.3,16527,2)
;;=^5001460
;;^UTILITY(U,$J,358.3,16528,0)
;;=C81.90^^61^775^94
;;^UTILITY(U,$J,358.3,16528,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16528,1,3,0)
;;=3^Hodgkin Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,16528,1,4,0)
;;=4^C81.90
;;^UTILITY(U,$J,358.3,16528,2)
;;=^5001451
;;^UTILITY(U,$J,358.3,16529,0)
;;=D89.2^^61^775^95
;;^UTILITY(U,$J,358.3,16529,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16529,1,3,0)
;;=3^Hypergammaglobulenemia,Unspec
;;^UTILITY(U,$J,358.3,16529,1,4,0)
;;=4^D89.2
;;^UTILITY(U,$J,358.3,16529,2)
;;=^5002455
;;^UTILITY(U,$J,358.3,16530,0)
;;=D05.12^^61^775^98
;;^UTILITY(U,$J,358.3,16530,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16530,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Left Breast
;;^UTILITY(U,$J,358.3,16530,1,4,0)
;;=4^D05.12
;;^UTILITY(U,$J,358.3,16530,2)
;;=^5001931
;;^UTILITY(U,$J,358.3,16531,0)
;;=D05.11^^61^775^99
;;^UTILITY(U,$J,358.3,16531,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16531,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Right Breast
;;^UTILITY(U,$J,358.3,16531,1,4,0)
;;=4^D05.11
;;^UTILITY(U,$J,358.3,16531,2)
;;=^5001930
;;^UTILITY(U,$J,358.3,16532,0)
;;=D05.10^^61^775^100
;;^UTILITY(U,$J,358.3,16532,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16532,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Unspec Breast
;;^UTILITY(U,$J,358.3,16532,1,4,0)
;;=4^D05.10
;;^UTILITY(U,$J,358.3,16532,2)
;;=^5001929
;;^UTILITY(U,$J,358.3,16533,0)
;;=D50.0^^61^775^101
;;^UTILITY(U,$J,358.3,16533,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16533,1,3,0)
;;=3^Iron Deficiency Anemia Secondary to Blood Loss
;;^UTILITY(U,$J,358.3,16533,1,4,0)
;;=4^D50.0
;;^UTILITY(U,$J,358.3,16533,2)
;;=^267971
;;^UTILITY(U,$J,358.3,16534,0)
;;=D50.9^^61^775^102
;;^UTILITY(U,$J,358.3,16534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16534,1,3,0)
;;=3^Iron Deficiency Anemia,Unspec
;;^UTILITY(U,$J,358.3,16534,1,4,0)
;;=4^D50.9
;;^UTILITY(U,$J,358.3,16534,2)
;;=^5002283
;;^UTILITY(U,$J,358.3,16535,0)
;;=C46.9^^61^775^103
;;^UTILITY(U,$J,358.3,16535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16535,1,3,0)
;;=3^Kaposi's Sarcoma,Unspec
;;^UTILITY(U,$J,358.3,16535,1,4,0)
;;=4^C46.9
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10N 3769 printed Sep 23, 2025@19:35:25 Page 2
IBDEI10N ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16523,1,4,0)
+2 ;;=4^D57.02
+3 ;;^UTILITY(U,$J,358.3,16523,2)
+4 ;;=^5002308
+5 ;;^UTILITY(U,$J,358.3,16524,0)
+6 ;;=D68.32^^61^775^89
+7 ;;^UTILITY(U,$J,358.3,16524,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,16524,1,3,0)
+10 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
+11 ;;^UTILITY(U,$J,358.3,16524,1,4,0)
+12 ;;=4^D68.32
+13 ;;^UTILITY(U,$J,358.3,16524,2)
+14 ;;=^5002357
+15 ;;^UTILITY(U,$J,358.3,16525,0)
+16 ;;=C22.2^^61^775^90
+17 ;;^UTILITY(U,$J,358.3,16525,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,16525,1,3,0)
+20 ;;=3^Hepatoblastoma
+21 ;;^UTILITY(U,$J,358.3,16525,1,4,0)
+22 ;;=4^C22.2
+23 ;;^UTILITY(U,$J,358.3,16525,2)
+24 ;;=^5000935
+25 ;;^UTILITY(U,$J,358.3,16526,0)
+26 ;;=D58.9^^61^775^92
+27 ;;^UTILITY(U,$J,358.3,16526,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,16526,1,3,0)
+30 ;;=3^Hereditary Hemolytic Anemia,Unspec
+31 ;;^UTILITY(U,$J,358.3,16526,1,4,0)
+32 ;;=4^D58.9
+33 ;;^UTILITY(U,$J,358.3,16526,2)
+34 ;;=^5002322
+35 ;;^UTILITY(U,$J,358.3,16527,0)
+36 ;;=C81.99^^61^775^93
+37 ;;^UTILITY(U,$J,358.3,16527,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,16527,1,3,0)
+40 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
+41 ;;^UTILITY(U,$J,358.3,16527,1,4,0)
+42 ;;=4^C81.99
+43 ;;^UTILITY(U,$J,358.3,16527,2)
+44 ;;=^5001460
+45 ;;^UTILITY(U,$J,358.3,16528,0)
+46 ;;=C81.90^^61^775^94
+47 ;;^UTILITY(U,$J,358.3,16528,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,16528,1,3,0)
+50 ;;=3^Hodgkin Lymphoma,Unspec Site
+51 ;;^UTILITY(U,$J,358.3,16528,1,4,0)
+52 ;;=4^C81.90
+53 ;;^UTILITY(U,$J,358.3,16528,2)
+54 ;;=^5001451
+55 ;;^UTILITY(U,$J,358.3,16529,0)
+56 ;;=D89.2^^61^775^95
+57 ;;^UTILITY(U,$J,358.3,16529,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,16529,1,3,0)
+60 ;;=3^Hypergammaglobulenemia,Unspec
+61 ;;^UTILITY(U,$J,358.3,16529,1,4,0)
+62 ;;=4^D89.2
+63 ;;^UTILITY(U,$J,358.3,16529,2)
+64 ;;=^5002455
+65 ;;^UTILITY(U,$J,358.3,16530,0)
+66 ;;=D05.12^^61^775^98
+67 ;;^UTILITY(U,$J,358.3,16530,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,16530,1,3,0)
+70 ;;=3^Intraductal Carcinoma in Situ,Left Breast
+71 ;;^UTILITY(U,$J,358.3,16530,1,4,0)
+72 ;;=4^D05.12
+73 ;;^UTILITY(U,$J,358.3,16530,2)
+74 ;;=^5001931
+75 ;;^UTILITY(U,$J,358.3,16531,0)
+76 ;;=D05.11^^61^775^99
+77 ;;^UTILITY(U,$J,358.3,16531,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,16531,1,3,0)
+80 ;;=3^Intraductal Carcinoma in Situ,Right Breast
+81 ;;^UTILITY(U,$J,358.3,16531,1,4,0)
+82 ;;=4^D05.11
+83 ;;^UTILITY(U,$J,358.3,16531,2)
+84 ;;=^5001930
+85 ;;^UTILITY(U,$J,358.3,16532,0)
+86 ;;=D05.10^^61^775^100
+87 ;;^UTILITY(U,$J,358.3,16532,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,16532,1,3,0)
+90 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
+91 ;;^UTILITY(U,$J,358.3,16532,1,4,0)
+92 ;;=4^D05.10
+93 ;;^UTILITY(U,$J,358.3,16532,2)
+94 ;;=^5001929
+95 ;;^UTILITY(U,$J,358.3,16533,0)
+96 ;;=D50.0^^61^775^101
+97 ;;^UTILITY(U,$J,358.3,16533,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,16533,1,3,0)
+100 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
+101 ;;^UTILITY(U,$J,358.3,16533,1,4,0)
+102 ;;=4^D50.0
+103 ;;^UTILITY(U,$J,358.3,16533,2)
+104 ;;=^267971
+105 ;;^UTILITY(U,$J,358.3,16534,0)
+106 ;;=D50.9^^61^775^102
+107 ;;^UTILITY(U,$J,358.3,16534,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,16534,1,3,0)
+110 ;;=3^Iron Deficiency Anemia,Unspec
+111 ;;^UTILITY(U,$J,358.3,16534,1,4,0)
+112 ;;=4^D50.9
+113 ;;^UTILITY(U,$J,358.3,16534,2)
+114 ;;=^5002283
+115 ;;^UTILITY(U,$J,358.3,16535,0)
+116 ;;=C46.9^^61^775^103
+117 ;;^UTILITY(U,$J,358.3,16535,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,16535,1,3,0)
+120 ;;=3^Kaposi's Sarcoma,Unspec
+121 ;;^UTILITY(U,$J,358.3,16535,1,4,0)
+122 ;;=4^C46.9
